Tango Therapeutics, Inc.
TNGX
$17.92
$0.623.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -38.75M | 15.88M | -38.85M | -39.88M | -37.67M |
| Total Depreciation and Amortization | 479.00K | 555.00K | 625.00K | 622.00K | 620.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.15M | 7.04M | 6.87M | 7.57M | 7.55M |
| Change in Net Operating Assets | 2.40M | -54.43M | -5.16M | -10.02M | -7.15M |
| Cash from Operations | -29.72M | -30.95M | -36.52M | -41.70M | -36.65M |
| Capital Expenditure | -222.00K | -151.00K | -624.00K | -51.00K | -124.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -135.50M | 47.63M | 17.40M | 30.65M | 52.18M |
| Cash from Investing | -135.72M | 47.48M | 16.78M | 30.60M | 52.06M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 219.41M | 2.54M | 581.00K | 2.00K | 969.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -36.00K | -- | -- | -- | -- |
| Cash from Financing | 219.38M | 2.54M | 581.00K | 2.00K | 969.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 53.94M | 19.07M | -19.16M | -11.10M | 16.38M |